All News #Library
Rare Diseases
FDA Rejects Atara’s blood Cancer Treatment
13 Jan 2026 //
REUTERS
Pierre Fabre Pharma Responds to Fda`s CRL for Tabelecleucel
12 Jan 2026 //
PR NEWSWIRE
FDA declines to approve Atara Biotherapeutics` cancer therapy
17 Jan 2025 //
PRESS RELEASE
Atara Biotherapeutics’ Ebvallo™ Wins Prix Galien Award for Orphan/Rare Diseases
21 Jun 2024 //
BUSINESSWIRE

Market Place
Sourcing Support